Systemic Redox Status of Rats Treated with Different Doses of Perfluorocarbon Based Blood Substitute- Perftoran®
, , , , , , , , , , y
20 sept 2022
Acerca de este artículo
Publicado en línea: 20 sept 2022
Páginas: 209 - 216
Recibido: 13 ago 2022
Aceptado: 25 ago 2022
DOI: https://doi.org/10.2478/sjecr-2022-0034
Palabras clave
© 2022 Morozova Elena et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Elena, Morozova
Department of Human PathologyMoscow, Russian Federation
Sergey, Vorobyev
Department of Human PathologyMoscow, Russian Federation
Sergey, Bolevich
Department of Human PathologyMoscow, Russian Federation
Stefani, Bolevich
Department of Human PathologyMoscow, Russian Federation
Alexander, Saltykov
Department of Human PathologyMoscow, Russian Federation
Alexandra, Orlova
Department of Human PathologyMoscow, Russian Federation
Tatiana, Sinelnikova
Department of Human PathologyMoscow, Russian Federation
Maria, Kruglova
Department of Human PathologyMoscow, Russian Federation
Bella, Morgan
Department of Human PathologyMoscow, Russian Federation
Anastasia, Mikhaleva
Department of Human PathologyMoscow, Russian Federation
Alexander, Khitrov
Department of Human PathologyMoscow, Russian Federation
Jakovljevic, Vladimir
Department of Human PathologyMoscow, Russian Federation
University of Kragujevac, Faculty of Medical Sciences, Department of PhysiologyKragujevac, Serbia